Cargando…
Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes
OBJECTIVE: Over half of newly diagnosed obese African Americans with diabetic ketoacidosis (DKA) discontinue insulin therapy and go through a period of near-normoglycemia remission. This subtype of diabetes is known as ketosis-prone type 2 diabetes (KPDM). RESEARCH DESIGN AND METHODS: To investigate...
Autores principales: | Umpierrez, Guillermo E., Smiley, Dawn, Robalino, Gonzalo, Peng, Limin, Gosmanov, Aidar R., Kitabchi, Abbas E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827521/ https://www.ncbi.nlm.nih.gov/pubmed/20028938 http://dx.doi.org/10.2337/dc09-1369 |
Ejemplares similares
-
Effects of Intravenous Glucose Load on Insulin Secretion in Patients With Ketosis-Prone Diabetes During Near-Normoglycemia Remission
por: Gosmanov, Aidar R., et al.
Publicado: (2010) -
Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis: A randomized controlled trial
por: Umpierrez, Guillermo E., et al.
Publicado: (2009) -
Pathogenesis of A(−)β(+) Ketosis-Prone Diabetes
por: Patel, Sanjeet G., et al.
Publicado: (2013) -
Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?
por: Liu, Beiyan, et al.
Publicado: (2013) -
Metabolomics, Stable Isotopes, and A(−)β(+) Ketosis-Prone Diabetes
por: Ramos-Roman, Maria A., et al.
Publicado: (2013)